Maze Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
MAZE on Nasdaq
Location
171 Oyster Point Boulevard, Suite 300, South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 10/14/2024

Maze Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard H. Scheller Director $0 Sep 22, 2025
Atul Dandekar Csbo Sep 22, 2025
Amy Bachrodt SVP, Finance Sep 22, 2025
Harold Bernstein President, R&D & CMO Sep 22, 2025
Courtney Phillips GC and Corp. Secretary Sep 22, 2025
Nancy C. Andrews Director Sep 22, 2025
James Brush Director Jan 30, 2025
Alan Colowick Director Jan 30, 2025
Neil Exter Director Sep 22, 2025
Charles J. Homcy Director Sep 22, 2025
Jason V. Coloma Chief Executive Officer, Director Sep 22, 2025
Jonathan E. Lim Director Sep 22, 2025
ARCH Venture Partners X, LLC 10%+ Owner Jan 30, 2025
Daniel K. Spiegelman Director Sep 22, 2025
Jeffrey K. Tong Director Jan 30, 2025
Third Rock Ventures IV, L.P. 10%+ Owner Feb 3, 2025
Misbah Tahir Chief Financial Officer Sep 2, 2025
Catherine A. Sohn Director Sep 22, 2025
Herve Hoppenot Director Oct 6, 2025
Sekar Kathiresan Director Sep 22, 2025

Recent Insider Transactions by Companies or Individuals for Maze Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.